integrated genomic analyses ovarian carcinoma
catalogue molecular aberrations cause ovarian cancer critical developing deploying therapies will improve patients lives cancer genome atlas project analysed messenger rna expression microrna expression promoter methylation dna copy number high-grade serous ovarian adenocarcinomas dna sequences exons coding genes tumours report high-grade serous ovarian cancer characterized tp53 mutations almost tumours % low prevalence statistically recurrent somatic mutations nine genes including nf1 brca1 brca2 rb1 cdk12 significant focal dna copy number aberrations promoter methylation events involving genes analyses delineated four ovarian cancer transcriptional subtypes three microrna subtypes four promoter methylation subtypes transcriptional signature associated survival duration shed new light impact tumours brca1/ brca1 brca2 ccne1 aberrations survival pathway analyses suggested homologous recombination defective half tumours analysed notch foxm1 signalling involved serous ovarian cancer pathophysiology
